NaseemAJaffraniMDFACC, FSCAI

Clinical Trials

• Study of the Safety and Efficacy of Apadenoson for Detection of Myocardial Perfusion Defects Using SPECT MPI Start of enrollment: 2009 Nov 01

  Terminated

  Phase 3

• Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus Start of enrollment: 2010 Jun 18

  Completed

  Phase 3

• Efficacy and Safety of Ularitide for the Treatment of Acute Decompensated Heart Failure Start of enrollment: 2012 Jul 01

  Completed

  Phase 3

• Study of the Efficacy and Safety of STI-5656 (Abivertinib Maleate) in Subjects Hospitalized With COVID-19 Start of enrollment: 2020 Oct 09

  Completed

  Phase 2

• Study of Inclisiran to Prevent Cardiovascular (CV) Events in Participants With Established Cardiovascular Disease Start of enrollment: 2021 Nov 23

  Active, not recruiting

  Phase 3

• Artificial Intelligence Mobile Health Trial Of A Digital Platform To Optimize GDMT Using Wearable Sensors Start of enrollment: 2020 Jan 27

  Active, not recruiting

  Not Applicable

• A Pivotal Study to Evaluate the Efficacy of Lorundrostat in Subjects With Uncontrolled Hypertension on a Standardized Antihypertensive Medication Regimen Start of enrollment: 2023 Mar 13

  Recruiting

  Phase 2

  Roles: Contact

• The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Renal Function in Adults Living With Obesity (TRIUMPH-OUTCOMES) Start of enrollment: 2024 Apr 30

  Recruiting

  Phase 3

• A Study to Investigate the Effect of Lepodisiran on the Reduction of Major Adverse Cardiovascular Events in Adults With Elevated Lipoprotein(a) - ACCLAIM-Lp(a) Start of enrollment: 2024 Mar 05

  Recruiting

  Phase 3

• A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients. Start of enrollment: 2023 Mar 09

  Recruiting

  Phase 3

• Join now to see all